Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000111 |
Acetylcysteine |
Acetylcysteine inhibits the reaction [Aclarubicin results in increased expression of GATA1 mRNA] | decreases reaction|increases expression | 10656287
|
D000111 |
Acetylcysteine |
Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA] | decreases reaction|increases expression | 10656287
|
D015250 |
Aclarubicin |
Acetylcysteine inhibits the reaction [Aclarubicin results in increased expression of GATA1 mRNA] | decreases reaction|increases expression | 10656287
|
D015250 |
Aclarubicin |
Aclarubicin promotes the reaction [GATA1 protein binds to GSTP1 promoter] | affects binding|increases reaction | 14623254
|
D015250 |
Aclarubicin |
Aclarubicin results in increased activity of GATA1 protein | increases activity | 14623254
|
D015250 |
Aclarubicin |
Aclarubicin results in increased expression of GATA1 mRNA | increases expression | 10656287
|
D015250 |
Aclarubicin |
pyrrolidine dithiocarbamic acid inhibits the reaction [Aclarubicin results in increased expression of GATA1 mRNA] | decreases reaction|increases expression | 10656287
|
D015250 |
Aclarubicin |
Quercetin inhibits the reaction [Aclarubicin results in increased expression of GATA1 mRNA] | decreases reaction|increases expression | 10656287
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of GATA1 mRNA | affects expression | 16483693
|
D001205 |
Ascorbic Acid |
[Tretinoin co-treated with Ascorbic Acid] results in increased expression of GATA1 mRNA | affects cotreatment|increases expression | 16443354
|
D020148 |
Butyric Acid |
Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA] | decreases reaction|increases expression | 10656287
|
D020148 |
Butyric Acid |
Butyric Acid results in increased expression of GATA1 mRNA | increases expression | 10656287 14757314
|
D020148 |
Butyric Acid |
chebulinic acid inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA] | decreases reaction|increases expression | 14769215
|
D020148 |
Butyric Acid |
pyrrolidine dithiocarbamic acid inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA] | decreases reaction|increases expression | 10656287
|
D020148 |
Butyric Acid |
Quercetin inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA] | decreases reaction|increases expression | 10656287
|
D020148 |
Butyric Acid |
tellimagrandin I inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA] | decreases reaction|increases expression | 14757314
|
D002118 |
Calcium |
Calcium affects the expression of GATA1 mRNA | affects expression | 15913539
|
D002211 |
Capsaicin |
Capsaicin results in increased expression of GATA1 mRNA | increases expression | 17603282
|
C103481 |
chebulinic acid |
chebulinic acid inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA] | decreases reaction|increases expression | 14769215
|
C103481 |
chebulinic acid |
chebulinic acid results in decreased expression of GATA1 mRNA | decreases expression | 14769215
|
C014347 |
decitabine |
[decitabine co-treated with trichostatin A] results in increased expression of GATA1 mRNA | affects cotreatment|increases expression | 17185465
|
D004317 |
Doxorubicin |
Doxorubicin analog results in increased activity of GATA1 protein | increases activity | 17097070
|
D004317 |
Doxorubicin |
Doxorubicin analog results in increased expression of GATA1 mRNA | increases expression | 17097070
|
D004317 |
Doxorubicin |
Doxorubicin promotes the reaction [GATA1 protein binds to GSTP1 promoter] | affects binding|increases reaction | 14623254
|
D004317 |
Doxorubicin |
Doxorubicin results in increased activity of GATA1 protein | increases activity | 14623254
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of GATA1 mRNA | increases expression | 17097070
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased mutagenesis of GATA1 gene | increases mutagenesis | 16966598
|
D018021 |
Lithium Chloride |
GATA1 protein results in decreased susceptibility to [Lithium Chloride co-treated with Tretinoin] | affects cotreatment|decreases response to substance | 19230972
|
C467566 |
pomalidomide |
pomalidomide results in decreased expression of GATA1 mRNA | decreases expression | 15292067
|
C467566 |
pomalidomide |
pomalidomide results in decreased expression of GATA1 protein | decreases expression | 15292067
|
C020972 |
pyrrolidine dithiocarbamic acid |
pyrrolidine dithiocarbamic acid inhibits the reaction [Aclarubicin results in increased expression of GATA1 mRNA] | decreases reaction|increases expression | 10656287
|
C020972 |
pyrrolidine dithiocarbamic acid |
pyrrolidine dithiocarbamic acid inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA] | decreases reaction|increases expression | 10656287
|
D011794 |
Quercetin |
Quercetin inhibits the reaction [Aclarubicin results in increased expression of GATA1 mRNA] | decreases reaction|increases expression | 10656287
|
D011794 |
Quercetin |
Quercetin inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA] | decreases reaction|increases expression | 10656287
|
C087926 |
tellimagrandin I |
tellimagrandin I inhibits the reaction [Butyric Acid results in increased expression of GATA1 mRNA] | decreases reaction|increases expression | 14757314
|
C087926 |
tellimagrandin I |
tellimagrandin I results in decreased expression of GATA1 mRNA | decreases expression | 14757314
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of GATA1 mRNA | increases expression | 12377990
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of GATA1 mRNA | decreases expression | 15644576
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate promotes the reaction [GATA1 protein binds to GSTP1 promoter] | affects binding|increases reaction | 14623254
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased activity of GATA1 protein | increases activity | 14623254
|
D014212 |
Tretinoin |
[Tretinoin co-treated with Ascorbic Acid] results in increased expression of GATA1 mRNA | affects cotreatment|increases expression | 16443354
|
D014212 |
Tretinoin |
GATA1 protein results in decreased susceptibility to [Lithium Chloride co-treated with Tretinoin] | affects cotreatment|decreases response to substance | 19230972
|
C012589 |
trichostatin A |
[decitabine co-treated with trichostatin A] results in increased expression of GATA1 mRNA | affects cotreatment|increases expression | 17185465
|
D014638 |
Vanadates |
Vanadates results in increased expression of GATA1 protein | increases expression | 16137666
|
D015215 |
Zidovudine |
Zidovudine results in decreased activity of GATA1 protein | decreases activity | 10651068 8599995
|
D015215 |
Zidovudine |
Zidovudine results in decreased expression of GATA1 mRNA | decreases expression | 8599995
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Capsaicin |
8.26 | 18926900 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.26 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.43 | 18287403 |
MESH:D000163 |
Acquired Immunodeficiency Syndrome |
|
Zidovudine |
4.69 | 9612607 |
MESH:D058186 |
Acute Kidney Injury |
|
Capsaicin |
4.42 | 18460982 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.54 | 17418594 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
3.64 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.25 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.42 | 21441931 |
MESH:D000505 |
Alopecia |
|
Capsaicin |
9.23 | 17569567 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
9.23 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.83 | 11748828 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
4.12 | 17084956 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.00 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.23 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.31 | 16456186 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.85 | 15336622 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
4.28 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.27 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.54 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.54 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.66 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.68 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.57 | 14601052 |
MESH:D001919 |
Bradycardia |
|
Capsaicin |
4.93 | 18207255 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
4.76 | 14991843 |
MESH:D002545 |
Brain Ischemia |
|
Capsaicin |
4.84 | 19211983 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
8.71 | 17150277 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
8.71 | 16436596 15144691 18412241 16357521 16651633 |
MESH:D001943 |
Breast Neoplasms |
|
Ascorbic Acid |
2.91 | 16443354 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.91 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.91 | 16115903 18695136 15994142 16935488 11325840 15634643 18382427 16264153 17369602 15939500 16322301 19526202 16096432 15136595 15567936 18628466 15668708 15993339 15692762 17426702 17983394 18234424 16826403 16595493 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
2.91 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.91 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.91 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.46 | 16813970 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
5.42 | 16962696 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.68 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.69 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.03 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
4.59 | 16234567 17876044 16023760 18059187 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
4.59 | 19519916 12508355 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.59 | 1917145 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.82 | 17234771 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.10 | 1485588 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Acetylcysteine |
13.97 | 17015178 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
13.97 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
13.97 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
13.97 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
13.97 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
6.56 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.56 | 18670907 16120746 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.44 | 17308081 16269455 17007740 15792986 16612575 16364871 15476868 16651473 16242529 16109756 17924179 17351982 15811867 17131338 16278810 16731534 16952015 17329180 16455267 17519947 17928571 18627295 17974986 15505089 17382496 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.90 | 17334414 16243910 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.02 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Acetylcysteine |
7.12 | 18226522 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
7.12 | 16003739 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
5.86 | 17160924 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.46 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.05 | 16835633 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.03 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.58 | 15340226 8697196 15668235 12621046 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.58 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.57 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
3.86 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
3.86 | 17148506 19056647 11134977 15741050 17191121 19440933 16640504 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
3.47 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.47 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
3.47 | 18095365 18852136 |
MESH:D003139 |
Common Cold |
|
Ascorbic Acid |
5.35 | 17323712 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.95 | 14669216 17141729 |
MESH:D003371 |
Cough |
|
Capsaicin |
5.05 | 10350223 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.41 | 20055451 15322242 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.41 | 10589399 9142499 16925845 9224671 17551590 9211117 9125849 8800419 9664655 14991402 |
MESH:D003550 |
Cystic Fibrosis |
|
Acetylcysteine |
4.26 | 19747007 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
3.62 | 19496084 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Ascorbic Acid |
4.45 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.45 | 17107852 |
MESH:D004314 |
Down Syndrome |
marker/mechanism |
|
| |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetylcysteine |
6.15 | 11287661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.15 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.15 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
13.23 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
13.23 | 11462148 |
MESH:D004362 |
Drug Toxicity |
|
Zidovudine |
13.23 | 15040536 |
MESH:D004381 |
Duodenal Ulcer |
|
Capsaicin |
4.56 | 10671773 11535926 |
OMIM:300367 |
DYSERYTHROPOIETIC ANEMIA WITH THROMBOCYTOPENIA |
marker/mechanism |
|
| |
MESH:C538011 |
Eales disease |
|
Ascorbic Acid |
5.35 | 9068938 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
5.86 | 18357618 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.56 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
6.56 | 8273558 9599246 8113982 16716910 7812673 11698051 15177302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.51 | 16714409 15322242 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.51 | 18230668 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
13.60 | 19294695 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
13.60 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
7.30 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.30 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.91 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.03 | 18037988 |
MESH:D004935 |
Esophageal Diseases |
|
Capsaicin |
5.57 | 19566590 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.51 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.51 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Zidovudine |
3.79 | 18299183 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.33 | 11858732 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.46 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
14.07 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.07 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
14.07 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Capsaicin |
26.67 | 18405923 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
26.67 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
26.67 | 16436596 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
26.67 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
26.67 | 17312396 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
26.67 | 18801729 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
6.24 | 16651633 18412241 16357521 |
MESH:D005910 |
Glioma |
|
Quercetin |
6.24 | 17643826 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.47 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
12.48 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
12.48 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
12.48 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.03 | 16084493 |
MESH:D006356 |
Heartburn |
|
Capsaicin |
5.57 | 19566590 |
MESH:D006330 |
Heart Defects, Congenital |
|
Ascorbic Acid |
10.84 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.84 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.84 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.39 | 14766674 16330681 16879835 16144979 16244372 18674790 18006777 16244371 16495754 12587719 17875725 16707910 17888722 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.26 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.78 | 15692506 |
MESH:D006402 |
Hematologic Diseases |
|
Zidovudine |
4.59 | 12579204 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.21 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.76 | 15340226 12621046 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Ascorbic Acid |
3.43 | 16863852 16490937 |
MESH:D015658 |
HIV Infections |
|
Zidovudine |
3.42 | 11363243 20032539 17358032 11141242 11698656 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.30 | 18501091 15147373 17606976 |
MESH:D006869 |
Hydronephrosis |
|
Lithium Chloride |
12.60 | 19797860 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
12.60 | 16959395 15340226 16354765 8697196 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Capsaicin |
7.88 | 17043245 17434803 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.88 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.44 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
3.92 | 18262572 11834736 |
MESH:D006973 |
Hypertension |
|
Quercetin |
5.06 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.06 | 18850075 18670907 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.12 | 17581917 |
MESH:D007249 |
Inflammation |
|
Capsaicin |
8.13 | 16956363 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.13 | 12878042 12200463 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
8.13 | 15177302 7812673 11698051 8273558 7562506 |
MESH:D007251 |
Influenza, Human |
|
pyrrolidine dithiocarbamic acid |
11.14 | 18473937 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
11.14 | 16624496 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.64 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.53 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.53 | 15992940 17551590 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.82 | 17086741 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.14 | 15369732 16775033 15699352 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
6.14 | 16962696 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.03 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
7.65 | 17379185 |
MESH:D007680 |
Kidney Neoplasms |
|
Zidovudine |
7.65 | 12579204 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.92 | 16316344 |
MESH:D007938 |
Leukemia |
|
decitabine |
10.17 | 18980019 19235587 |
MESH:D007938 |
Leukemia |
|
Quercetin |
10.17 | 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
10.17 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.03 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Zidovudine |
4.29 | 20370541 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
9.16 | 19117987 18454857 17236224 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
9.16 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
6.11 | 18460780 19387464 19010910 18206229 17679729 18704418 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
6.11 | 17596541 16294345 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
6.11 | 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.33 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.07 | 16766008 17301526 17217047 19029980 17107899 16331271 17368321 16935935 9834237 15748426 19075265 19225113 17294898 16140955 17712046 17361223 17339181 19642359 16891316 16788101 12679006 17506722 17649720 19035177 16823087 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.21 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
6.60 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pyrrolidine dithiocarbamic acid |
6.60 | 15078482 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
6.60 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.60 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
6.60 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Capsaicin |
3.23 | 16956363 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
4.40 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.40 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Ascorbic Acid |
13.52 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
13.52 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
13.52 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
13.52 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Acetylcysteine |
7.76 | 12815614 |
MESH:D008171 |
Lung Diseases |
|
Ascorbic Acid |
7.76 | 16863852 |
MESH:D055370 |
Lung Injury |
|
pyrrolidine dithiocarbamic acid |
4.86 | 16129981 |
MESH:D008175 |
Lung Neoplasms |
|
Ascorbic Acid |
10.47 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
10.47 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
10.47 | 16271038 6695378 16019985 17703301 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
10.47 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
10.47 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
10.47 | 11807781 |
MESH:D008175 |
Lung Neoplasms |
|
Zidovudine |
10.47 | 18800350 |
MESH:D008223 |
Lymphoma |
|
decitabine |
12.16 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
12.16 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
12.16 | 15790496 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.68 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
11.26 | 15621674 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
11.26 | 15375218 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
9.73 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
9.73 | 10767621 18041768 10838139 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
9.73 | 8985016 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.73 | 17453147 |
MESH:D008545 |
Melanoma |
|
decitabine |
7.17 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
7.17 | 16827129 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
7.17 | 16752155 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
7.17 | 16505122 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
5.86 | 17943659 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.29 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.01 | 17638057 |
MESH:D048629 |
Micronuclei, Chromosome-Defective |
|
Zidovudine |
5.71 | 17358032 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.38 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.66 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Capsaicin |
11.84 | 17505005 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
11.84 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
11.84 | 18172295 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.23 | 18608210 19157545 16882708 19010910 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.23 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.84 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
5.84 | 19595682 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.91 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
3.69 | 19207477 |
MESH:D009362 |
Neoplasm Metastasis |
|
Acetylcysteine |
6.08 | 14720322 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
6.08 | 18259882 |
MESH:D009369 |
Neoplasms |
|
decitabine |
8.00 | 19116145 19470736 17925555 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
8.00 | 15185748 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.00 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
4.27 | 16707424 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.64 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.89 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.09 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.09 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Acetylcysteine |
7.35 | 19446573 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.35 | 9142499 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
5.28 | 17160924 16003739 16651423 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.20 | 15555623 |
MESH:D020078 |
Neurogenic Inflammation |
|
Capsaicin |
10.53 | 17961222 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
10.53 | 17929310 |
MESH:D009765 |
Obesity |
|
Ascorbic Acid |
5.22 | 17217161 |
MESH:D009765 |
Obesity |
|
Capsaicin |
5.22 | 19056576 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
5.86 | 17160924 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.70 | 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
4.09 | 19495926 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.01 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
11.02 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
11.02 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
11.02 | 16936753 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
11.02 | 19331143 |
MESH:D010146 |
Pain |
|
Capsaicin |
6.83 | 17434803 17043245 16996476 19081190 18987195 17084039 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.83 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
15.85 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
15.85 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
15.85 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
15.85 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
15.85 | 19294695 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
4.16 | 18922899 12065085 18404319 8330346 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.12 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.03 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.03 | 17638057 |
MESH:D011141 |
Polyuria |
|
Lithium Chloride |
5.87 | 19692487 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.43 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
3.87 | 19056647 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.06 | 11222880 11118676 11896295 11399792 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
11.99 | 17616702 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
11.99 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.24 | 16868541 15897917 16888761 15749863 18437689 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
pyrrolidine dithiocarbamic acid |
2.24 | 16139439 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
2.24 | 17292933 14715546 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
2.24 | 19789329 18798265 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.48 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.66 | 16723453 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Ascorbic Acid |
5.20 | 14606601 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.09 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
Capsaicin |
3.90 | 19211983 18460982 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Acetylcysteine |
9.44 | 12210543 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
pyrrolidine dithiocarbamic acid |
9.44 | 16129981 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.71 | 18990726 |
MESH:D012174 |
Retinitis Pigmentosa |
|
Ascorbic Acid |
3.27 | 16849425 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
10.53 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
10.53 | 16116481 16283617 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.87 | 15675481 16767912 18313854 17203757 17710206 15625365 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.11 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.66 | 17846226 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
5.42 | 16862918 |
MESH:D012871 |
Skin Diseases |
|
Ascorbic Acid |
3.18 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
13.10 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.10 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
13.10 | 8330346 8985016 18404319 11807781 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
13.10 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.44 | 17203757 15625365 16767912 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
3.43 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.43 | 17261132 |
MESH:D013274 |
Stomach Neoplasms |
|
Zidovudine |
3.43 | 17696246 |
MESH:D013276 |
Stomach Ulcer |
|
Acetylcysteine |
7.47 | 17918041 |
MESH:D013276 |
Stomach Ulcer |
|
Ascorbic Acid |
7.47 | 18726076 |
MESH:D020521 |
Stroke |
|
Ascorbic Acid |
4.19 | 16403987 16517955 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
Capsaicin |
5.59 | 17997062 |
MESH:D013921 |
Thrombocytopenia |
marker/mechanism |
|
| 16966598 |
OMIM:314050 |
THROMBOCYTOPENIA, PLATELET DYSFUNCTION, HEMOLYSIS, AND IMBALANCED GLOBIN SYNTHESIS |
marker/mechanism |
|
| |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
5.03 | 15790496 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.77 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
11.48 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
11.48 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
11.48 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.67 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.15 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
8.17 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
8.17 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
8.17 | 16720314 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.56 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
12.40 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
12.40 | 16752155 |
MESH:D014625 |
Vaginal Neoplasms |
|
Zidovudine |
4.63 | 12579204 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.47 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.09 | 17334414 16364871 17678736 17638931 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.93 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.12 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.85 | 16287080 |